Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
about
Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition.Targeting tumor-stromal interactions in bone metastasisA novel, rapid strategy to form dendritomas from human dendritic cells and hepatocellular carcinoma cell line HCCLM3 cells using mature dendritic cells derived from human peripheral blood CD14+ monocytes within 48 hours of in vitro culture.Novel immunotherapiesDirect visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.Progress in active-specific immunotherapy of brain malignancies.Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.New methods for assessing T-cell responses.Cancer gene therapy: developments to 2000.Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunityImmunotherapy: on the edge between experimental and clinical oncology.Dendritic cells and immunotherapy for malignant disease.Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.Dendritic cells for specific cancer immunotherapy.Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.Vaccines in oncology: background and clinical potential.Biological and clinical developments in melanoma vaccines.T-cell-directed cancer vaccines: the melanoma model.Science, medicine, and the future: Cellular immunotherapy for cancer.Recent advances in kidney cancer and metastatic disease.Recent advances in dendritic cell vaccines for cancer treatment.Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein.Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.Melanoma vaccination: state-of-the-art and experimental approaches.Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic miceNonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.Genetically modified dendritic cells--a new, promising cancer treatment strategy?The combination of chemotherapy and systemic immunotherapy and the concept of cure in murine leukemia and lymphoma.Aspects of cancer immunotherapy.The application of electroporation to transfect hematopoietic cells and to deliver drugs and vaccines transcutaneously for cancer treatment.Novel therapies for renal cell carcinoma--an update.Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Creating therapeutic cancer vaccines: notes from the battlefieldCellular vaccine therapy for cancer.Immunotherapy in multiple myeloma: current strategies and future prospects.Against the self: dendritic cells versus cancer.Clinical application of dendritic cells in cancer vaccination therapy.
P2860
Q24792515-EECB03FF-5A2A-45CD-B930-961F39D76438Q24801995-6405ADB5-A810-4479-8113-202CB514F738Q27024561-7490AE36-9444-4705-AF53-02C900D9DBE7Q33208820-0B25A8D1-07BA-49C0-ABF9-F8F01827C823Q33822677-60AD0E36-1A0C-4F33-9A66-3B6F5CBAC261Q34035564-5F7525BC-6818-4922-9DBA-E2DCDD9031BDQ34075068-361F5640-5139-4B27-AEBC-6FACEAEEE7C2Q34075717-95FADBF8-668E-4960-9A2D-012F500B4BAFQ34076691-E60C9259-5135-452F-BEA5-5C8A8BE29A5EQ34090963-AF20DBB4-3936-4CA0-A2EA-CA87ACBC54D3Q34096503-C8209FC1-B7C0-45A0-843E-FC35E57EFB95Q34172095-9D4E0505-0092-47E8-ADEE-E0C77171C1D4Q34216506-7929EF47-A635-499D-8B05-6D6882FFFE03Q34265381-A71BBBC4-D2DC-4DB9-B5AA-CFC4E8BBE655Q34280913-930C22AE-F117-45B7-A4C7-149DC264C365Q34353878-6DD003F1-8688-477A-B725-86053E1073F5Q34439914-0512F2FC-B2D6-47D0-B31A-FBF37910174BQ34452007-23B4D678-27C5-4A35-901F-DF1781AE6E13Q34452071-629F6093-7F96-4E8E-BA19-0C66CC65F5E0Q34455397-C80659ED-E190-427E-B7D1-7A967CDCFF78Q34459029-52DB3C64-5D48-4B91-B076-58B41053994DQ34480504-D86B58D2-D708-410F-89D3-851557BEA0B5Q34646946-EFA76F31-D4BA-474B-822A-785C426E10F5Q34724669-393F5099-6FB6-425F-BC16-C0A077B71485Q34734131-07F32430-0D0C-4672-B7BB-2B00B718F88EQ34734226-3BF021E4-57FC-4B53-983F-1AA7409A063DQ34776987-0A630285-B8AF-4DD2-ABAC-A108612C917CQ35022491-F069C241-8E0C-4D70-A9E1-5C1EFCB73B80Q35040829-F5890AAF-9A81-48CB-B426-890578056E0DQ35047632-863072C5-2709-46B4-A9F2-6D31E6072512Q35048340-E2526F0D-AD0E-45FB-9003-94857E1A2511Q35081106-003A4F44-8DE9-413A-8543-5C83F0C4F38AQ35094669-DFFD69D1-4808-4151-BEF5-291D206FF5A1Q35137164-AEC9FC7F-367C-40A4-BC74-F341A2D5DF53Q35142329-33977639-DF8E-4BB7-9114-0485BBAC4BDEQ35190925-AEA74394-3114-4979-A88B-878813AAF458Q35193459-5D03F545-FD10-47C5-9BFF-6A8E01F0DD6AQ35194182-CA3B6C32-9AD7-4B2C-9234-643B3D2CB481Q35219334-5106EB81-FDD7-4616-9BEF-AFA310AE05CDQ35219339-20A76386-CF8C-42C1-993E-0CA2C6A2D0A2
P2860
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
description
im März 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2000
@uk
name
Regression of human metastatic ...... or cell-dendritic cell hybrids
@en
Regression of human metastatic ...... or cell-dendritic cell hybrids
@nl
type
label
Regression of human metastatic ...... or cell-dendritic cell hybrids
@en
Regression of human metastatic ...... or cell-dendritic cell hybrids
@nl
prefLabel
Regression of human metastatic ...... or cell-dendritic cell hybrids
@en
Regression of human metastatic ...... or cell-dendritic cell hybrids
@nl
P2093
P356
P1433
P1476
Regression of human metastatic ...... or cell-dendritic cell hybrids
@en
P2093
A Zobywalski
B Hemmerlein
C A Müller
G A Müller
P Brossart
P2888
P356
10.1038/73193
P407
P577
2000-03-01T00:00:00Z
P6179
1021964373